Tandem Diabetes Care, Inc.

NASDAQ:TNDM

Medical - Devices

Healthcare
$17.05 +1.53%

+$0.24 today

Market cap
$1.19B
Beta
1.57
P/E (TTM)
-11.3
EPS (TTM)
-$1.38
52W Low $9.98High $29.65

Volume 2.35M

Average 2.43M

TNDM Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Tandem Diabetes Care, Inc.NASDAQ: TNDM

Net Margin · Q1 FY2026 · quarter ended Mar 2026

Net margin widens to -8.2%

Net margin was -8.2% in Q1 FY2026, up 47.4 pp from a year earlier. On a trailing-twelve-month basis it was -9.2%, up 7.5 pp year over year. Over 3 fiscal years it narrowed by 8.4 pp.

Context

  • Net margin widened in 1 of the last 3 fiscal years.

What to watch

Whether net margin reaches the consensus estimate from 18 analysts of -3.6% for the fiscal year ending Dec 2026, up from -20.2% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-8.2%-8.0 pp QoQ
Last fiscal yearDec 2025
-20.2%-10.0 pp YoY
LTMMar 2026
-9.2%+7.5 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+47.4 pp+13.0 pp-34.4 pp
1 year-10.0 pp+16.6 pp+26.5 pp
3 years-8.4 pp+24.3 pp+32.6 pp
5 years+27.8 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
-20.2%
Year-over-year change
-10.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How TNDM compares with its peers on the latest reported figures

  • TNDM's LTM Mar 2026 net margin of -9.2% is the 4th highest of the 7 companies compared; the peer median is -8.4%.
  • Its year-over-year change of +7.5 pp is the 3rd highest of 6, against a peer median of +6.8 pp.
  • Over three fiscal years its change of -8.4 pp compares with a peer median of +7.5 pp.
TNDM Competitors Peer median
Net Margin for TNDM and competitors
Company Period LTM level YoY 3-year change
DXCMDexCom, Inc.LTM Jun 202620.1% +6.8 pp+6.2 pp
PODDInsulet CorporationLTM Jun 202612.3% +2.3 pp+8.8 pp
MNKDMannKind CorporationLTM Mar 2026-6.6% -16.7 pp+89.3 pp
TNDMTandem Diabetes Care, Inc.LTM Mar 2026-9.2% +7.5 pp-8.4 pp
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026-10.2% —-6.4 pp
BBNXBeta Bionics, Inc.LTM Mar 2026-60.3% +41.4 pp+36100.7 pp
SENSSenseonics Holdings, Inc.LTM Mar 2026-214.2% +98.3 pp-1063.2 pp
MMEDVMiniMed Group, Inc.—— ——
GUTSFractyl Health, Inc. Common StockFY2025— ——
Peer median (excluding TNDM) -8.4%+6.8 pp+7.5 pp

Competitors are the stored peer set for TNDM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue702.8M801.22M747.72M940.2M1.01B
Cost of Revenue326.58M388.23M380.03M450.63M483.89M
Gross Profit376.22M412.99M367.69M489.57M530.85M
Gross Margin53.5%51.5%49.2%52.1%52.3%
Research & Development92.05M170.15M248.42M198.88M174.84M
Selling, General & Admin261.51M335.68M352.5M389.82M434.13M
Operating Expenses353.56M505.83M600.92M588.7M608.97M
Depreciation & Amortization13.85M14.33M15.72M158K17.67M
EBITDA34.06M(74.21M)(196.46M)(99.13M)(174.7M)
EBITDA Margin4.8%-9.3%-26.3%-10.5%-17.2%
Operating Income22.65M(92.85M)(233.23M)(99.13M)(78.12M)
Operating Margin3.2%-11.6%-31.2%-10.5%-7.7%
Interest Income674K6.06M22.86M17.99M9.09M
Interest Expense6.04M6.21M9.88M7.42M7.91M
Other Income / Expenses(6.75M)(4K)12.98M7.26M(122.15M)
Income Before Tax15.9M(92.85M)(220.25M)(91.87M)(200.27M)
Pre-Tax Margin2.3%-11.6%-29.5%-9.8%-19.7%
Income Tax Expense335K1.74M2.36M4.16M4.44M
Net Income15.57M(94.59M)(222.61M)(96.03M)(204.71M)
Net Margin2.2%-11.8%-29.8%-10.2%-20.2%
EPS (Basic)0.25(1.47)(3.43)(1.47)(3.04)
EPS (Diluted)0.24(1.47)(3.43)(1.47)(3.04)
Weighted Avg Shares63M64.15M64.9M65.45M67.29M
Weighted Avg Shares (Diluted)64.35M64.15M64.97M65.45M67.29M

Tandem Diabetes Care, Inc.

NASDAQ:TNDM

Intrinsic Alpha fair value

Locked

Current Price

$17.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.